Stronger Effect of Azilsartan on Reduction of Proteinuria Compared to Candesartan in Patients with CKD: A Randomized Crossover Trial

Introduction: Angiotensin receptor blockers (ARBs) are preferably used in hypertensive patients with CKD. Azilsartan is a strong antihypertensive ARB, but its antiproteinuric effects are not well understood. We compared the antiproteinuric effect of azilsartan and candesartan in CKD patients in an o...

詳細記述

書誌詳細

主要な著者:	Takaichi Suehiro, Kazuhiko Tsuruya, Hisako Yoshida, Hiroaki Tsujikawa, Shunsuke Yamada, Shigeru Tanaka, Akihiro Tsuchimoto, Masahiro Eriguchi, Kiichiro Fujisaki, Kumiko Torisu, Toshiaki Nakano, Takanari Kitazono
フォーマット:	Artigo
言語:	Inglês
出版事項:	Karger Publishers 2021-03-01
シリーズ:	Kidney & Blood Pressure Research
主題:	azilsartan candesartan ckd crossover trial proteinuria
オンライン･アクセス:	https://www.karger.com/Article/FullText/512365
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!